An observational study in Epilepsy, sponsored by Fondation Ophtalmologique Adolphe de Rothschild. Recruiting at 1 site in France. Open to participants aged 18 Years to 65 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-06.
Sponsored by Fondation Ophtalmologique Adolphe de Rothschild · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 10 studies in Epilepsy by Fondation Ophtalmologique Adolphe de Rothschild — 7 open to participants now, 7 under way, none of them phase 3. Epilepsy · Fondation Ophtalmologique Adolphe de Rothschild.
Among the 10 studies in Epilepsy by Fondation Ophtalmologique Adolphe de Rothschild, this one is one of 2 that started in 2025, is one of 7 observational ones, and was the 8th registered.
1,850 studies on the registry are indexed under Epilepsy; 418 are open to participants now.
Browse Epilepsy studies →7 of the 10 studies in Epilepsy by Fondation Ophtalmologique Adolphe de Rothschild are open now, in 1 country. Recruiting first, the newest first:
Fondation Ophtalmologique Adolphe de Rothschild · Sites in France
Ages 18+
Fondation Ophtalmologique Adolphe de Rothschild · Sites in France
Fondation Ophtalmologique Adolphe de Rothschild · Sites in France
Ages 18+
Fondation Ophtalmologique Adolphe de Rothschild · Sites in France
Ages 6–18
Fondation Ophtalmologique Adolphe de Rothschild · Sites in France
Ages up to 18
By country, each count listing its studies:
Of the 284 Epilepsy studies recruiting now, 113 (40%) set no upper age limit and 148 (52%) stop at 75 or younger; 138 take children under 18; 54 take healthy volunteers.
This study: 18 Years to 65 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
10 studies; the count open now beside each. This study's row is marked.
First in 2015; this study’s year is marked. 2 started in 2025.
This study's planned enrollment of 40 is below the median of 107 across 541 observational studies indexed under Epilepsy.
Median enrollment 76 across the 3 interventional studies, 50 across the 7 observational. Of the 3 that completed or were terminated, 0 (0%) have results posted.
This tab as a report to print or save as PDF → With an account.
Fondation Ophtalmologique Adolphe de Rothschild is the lead sponsor of 316 studies on the registry; 78 are open to participants now.
3 of the studies in Epilepsy by Fondation Ophtalmologique Adolphe de Rothschild that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07075380Fondation Ophtalmologique Adolphe de RothschildNational Survey on Physical and Sports Activity of Adults With Epilepsy | 2027-05 |
| NCT04451278Fondation Ophtalmologique Adolphe de RothschildRESting-state Functional MRI for Prediction of Post-surgical Prognosis In Pediatric Drug-Resistant Epilepsy | 2027-10 |
| NCT07026591Fondation Ophtalmologique Adolphe de RothschildEpilepsy and Driving | 2027-11 |
Add all 3 to your calendar (.ics) → With an account.
Among the 10 studies in Epilepsy by Fondation Ophtalmologique Adolphe de Rothschild, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Epilepsy can lead to cognitive impairments, particularly in attention, which may affect daily activities such as driving. Driving plays a key role in maintaining autonomy and is essential for the social and professional integration of people with epilepsy. Therefore, assessing fitness to drive is a major issue for individuals with epilepsy.
French legislation governing driving for people with epilepsy clearly outlines the periods during which a person is not permitted to drive. However, the means or methods for evaluating driving fitness in these individuals are not well defined. Currently, assessment is based more on a medical consultation than on a comprehensive evaluation of driving ability.
Using a driving simulator in combination with an EEG could be a valuable approach to better assess the impact of epilepsy-related cognitive impairments on driving performance.
Epileptic patients and healthy volunteers
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Individuals with epilepsy who drive at least once a month
healthy volunteers driving at leat once a month, matched to epileptic patients on age (+-/ 5 years), sex and driving experience (+/-3 years)
Speed
Mean speed during the simulated driving task
Time frame: Day 0
Phasic alertness
Phasic alertness on neuropsychological test (TAP)
Time frame: Day 0
Lane position
Mean lane position during the simulated driving task
Time frame: Day 0
Braking time
Mean braking time during the simulated driving task
Time frame: Day 0
Information processing time
Mean information processing time during the simulated driving task
Time frame: Day 0
Sustained attention
Sustained attention on neuropsychological test (TAP)
Time frame: Day 0
Divided attention
Divided attention on neuropsychological test (TAP)
Time frame: Day 0
Visual scanning
Visual scanning on neuropsychological test (TAP)
Time frame: Day 0
Started Nov 2025 (actual). Primary completion is estimated for Nov 2027, 24 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Fondation Ophtalmologique Adolphe de Rothschild →